Long-term safety and efficacy of eltrombopag in adults with chronic immune thrombocytopenia (ITP): Report of up to 5.5 years of treatment in EXTEND

Authors
Category Primary study
JournalBlood
Year 2012
This article has no abstract
Epistemonikos ID: 9aea3b484ec22897b5d0aca3cacaa80f643e33e8
First added on: Feb 05, 2025